Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Law (8)
- Genetics and Genomics (7)
- Medical Sciences (6)
- Medicine and Health Sciences (6)
- Genetic Structures (5)
-
- Intellectual Property Law (5)
- Biotechnology (4)
- Business (3)
- Business Law, Public Responsibility, and Ethics (3)
- Biomedical Engineering and Bioengineering (2)
- Engineering (2)
- Other Biomedical Engineering and Bioengineering (2)
- Other Genetics and Genomics (2)
- Policy Design, Analysis, and Evaluation (2)
- Public Affairs, Public Policy and Public Administration (2)
- Social and Behavioral Sciences (2)
- Cancer Biology (1)
- Cell and Developmental Biology (1)
- Health Law and Policy (1)
- Medical Biotechnology (1)
- Medical Genetics (1)
- Privacy Law (1)
Articles 1 - 9 of 9
Full-Text Articles in Life Sciences
Social Issues Of Genome Innovation And Intellectual Property, Elaine Alma Draper
Social Issues Of Genome Innovation And Intellectual Property, Elaine Alma Draper
RISK: Health, Safety & Environment (1990-2002)
Dr. Draper's focus is the use of personal information derived from genome research. She identifies several potential problems, including access to and control of genetic information, employment discrimination and social stratification. She also recommends possible solutions.
Maximizing The Return From Genome Research: Introduction, Thomas G. Field Jr.
Maximizing The Return From Genome Research: Introduction, Thomas G. Field Jr.
RISK: Health, Safety & Environment (1990-2002)
Professor Field introduces and explains the origins of the symposium.
Overview Of Federal Technology Transfer, Lawrence Rudolph
Overview Of Federal Technology Transfer, Lawrence Rudolph
RISK: Health, Safety & Environment (1990-2002)
Mr. Rudolph reviews approximately thirteen years of legal and political developments that have contributed to laws governing the extent to which private firms may secure rights in technology at least partly developed with federal funds.
The Human Genome Project And The Downside Of Federal Technology Transfer, Christopher J. Harnett
The Human Genome Project And The Downside Of Federal Technology Transfer, Christopher J. Harnett
RISK: Health, Safety & Environment (1990-2002)
Mr. Harnett argues that emphasizing technology transfer at institutions such as the National Institutes of Health will interfere with what should be regarded as their primary mission, basic research.
Technology Transfer: A View From The Trenches, Harvey Drucker
Technology Transfer: A View From The Trenches, Harvey Drucker
RISK: Health, Safety & Environment (1990-2002)
Dr. Drucker, who has lab-wide responsibility for technology transfer at Argonne National Laboratory, argues that transferring rights in discoveries made through tax supported research to private entities can contribute to public welfare in many ways.
Origins Of The Human Genome Project, Robert Mullan Cook-Deegan
Origins Of The Human Genome Project, Robert Mullan Cook-Deegan
RISK: Health, Safety & Environment (1990-2002)
Dr. Cook-Deegan recounts some of the scientific and political history leading to controversy about the proper mix of private and public roles in pursuing genome research and bringing its fruits to bear, e.g., in preventing and curing disease.
Technology Transfer And The Genome Project: Problems With Patenting Research Tools, Rebecca S. Eisenberg
Technology Transfer And The Genome Project: Problems With Patenting Research Tools, Rebecca S. Eisenberg
RISK: Health, Safety & Environment (1990-2002)
Professor Eisenberg argues against a system providing for federally-sponsored inventions to be patented if any associated person so desires. She believes that the system does not adequately weigh the possibility that the greatest social return from genome research will require some discoveries to be in the public domain.
Old Remedies In The Biotechnology Age: Moore V. Regents, Michelle J. Burke, Victoria M. Schmidt
Old Remedies In The Biotechnology Age: Moore V. Regents, Michelle J. Burke, Victoria M. Schmidt
RISK: Health, Safety & Environment (1990-2002)
The California Supreme Court, by excluding a potential remedy, has eliminated many concerns generated by a lower court decision resolving rights to the cell line derived from John Moore's spleen. Yet, the Supreme Court gave little attention to remedies that remain. The authors argue that a constructive trust, a remedy of considerable vintage and great flexibility, could be applied to achieve a just result in such circumstances without affecting the biotechnology world at large.
Book Review, Allan M. Wheatcraft
Book Review, Allan M. Wheatcraft
RISK: Health, Safety & Environment (1990-2002)
Review of the following book: SHELDON KRIMSKY, BIOTECHNICS AND SOCIETY: THE RISE OF INDUSTRIAL GENETICS. (Praeger 1991) [280 pp.] Bibliography, figures, index, list of acronyms used, tables. LC: 90-23214, ISBN: 0-275-93860-3. [Paper $17.95. P.O.B. 5007, Westport CT 06881.]